Eli Lilly in Advanced Talks to Acquire Kelonia Therapeutics for Over $2 Billion

Eli Lilly is ‌in ​advanced talks to ⁠acquire ​Kelonia Therapeutics for ⁠more ‌than $2 ​billion, The Wall ‌Street ‌Journal reported on ⁠Sunday.[#item_full_content]

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.